Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prophylactic application of fluoroquinolones for selective decontamination of the gut: friend or foe.

× No keyword cloud information.

20 in total

1. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors: Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal: Clin Infect Dis Date: 2002-02-13 Impact factor: 9.079

2. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice.

Authors: S Trifilio; A Verma; J Mehta
Journal: Bone Marrow Transplant Date: 2004-04 Impact factor: 5.483

3. Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.

Authors: Rajesh M Prabhu; Michelle A Elliott; Robin Patel
Journal: Clin Infect Dis Date: 2004-04-01 Impact factor: 9.079

Review 4. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

Authors: S H Zinner
Journal: Clin Infect Dis Date: 1999-09 Impact factor: 9.079

5. Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.

Authors: F Kroschinsky; G Wichmann; M Bornhauser; R Ordemann; U Schuler; G Ehninger; M Hanel
Journal: Transpl Infect Dis Date: 2002-09 Impact factor: 2.228

6. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.

Authors: C C Patrick
Journal: Pediatr Infect Dis J Date: 1997-01 Impact factor: 2.129

Review 7. Science and pragmatism in the treatment and prevention of neutropenic infection.

Authors: J Klastersky
Journal: J Antimicrob Chemother Date: 1998-06 Impact factor: 5.790

8. Changing bacterial ecology during a five-year period of selective intestinal decontamination.

Authors: W Lingnau; J Berger; F Javorsky; M Fille; F Allerberger; H Benzer
Journal: J Hosp Infect Date: 1998-07 Impact factor: 3.926

9. Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital.

Authors: A van Belkum; W Goessens; C van der Schee; N Lemmens-den Toom; M C Vos; J Cornelissen; E Lugtenburg; S de Marie; H Verbrugh; B Löwenberg; H Endtz
Journal: Emerg Infect Dis Date: 2001 Sep-Oct Impact factor: 6.883

10. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.

Authors: Dong Gun Lee; Su Mi Choi; Jung Hyun Choi; Jin Hong Yoo; Yoon Hee Park; Yoo Jin Kim; Seok Lee; Chang Ki Min; Hee Je Kim; Dong Wook Kim; Jong Wook Lee; Woo Sung Min; Wan Shik Shin; Chun Choo Kim
Journal: Korean J Intern Med Date: 2002-03 Impact factor: 2.884